Associations of Interleukin-6 Levels and Lipid Profiles in Women with Coronary Artery Disease: A Comparative Study across Menopausal and Reproductive Stages at RSUP. H. Adam Malik
Muhammad FG Siregar, Hariadi Supanto, Cut A Andra, Ichwanul Adenin, Letta S Lintang, Iman H Effendi, Immanuel DL Tobing, David J Subuh
Aims and background: Menopause alters the lipid profile by raising total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL C), and very low-density lipoprotein cholesterol (VLDL C) while lowering high-density lipoprotein cholesterol (HDL C). In women with cardiovascular risk linked to interleukin-6 (IL-6) and C-reactive protein (CRP) plasma levels, this study aimed to examine the connection between IL-6 levels and lipid profiles in both menopausal and reproductive women with coronary artery disease (CAD). Age, body mass index (BMI), smoking history, blood pressure, alcohol consumption, diabetes, and exercise frequency were found to be related to IL-6 concentrations.
Materials and methods: Observational analytical study with a case-control design was used in this study. Two groups (menopausal and reproductive women) of 44 women had their IL-6 levels and lipid profile checked. The data were then analyzed using a correlation test.
Results: The BMI, smoking behaviors, and family history of heart disease were observed to significantly differ between the menopausal and reproductive groups of women (p < 0.05). In both groups, there was a substantial relationship (p < 0.05) between IL-6 levels and lipid markers such as TC, LDL, and TG. The HDL levels did not differ statistically significantly (p > 0.05) between the two groups, however. The length of menopause and IL-6 levels were significantly correlated in the group of menopausal women (p < 0.05).
Conclusion: The lipid profile (total cholesterol, LDL, and triglycerides) and IL-6 levels were significantly correlated in menopausal women and reproductive women with CAD.
Clinical significance: Elevated IL-6 is associated with disturbance of lipid profile among both menopausal and reproductive women with CAD.
Du L, Xu B, Huang C, et al. Menopausal symptoms and perimenopausal healthcare-seeking behavior in women aged 40–60 years: A community-based cross-sectional survey in Shanghai, China. Int J Environ Res Public Health. 2020;17(8):2640. DOI: 10.3390/ijerph17082640.
Central Statistics Agency. Indonesian Statistics 2019. Jakarta; 2019. Available from: https://www.bps.go.id/id/publication/2019/07/04/daac1ba18cae1e90706ee58a/statistik-indonesia-2019.html.
Sari NIY, Adriani RB, Mudigdo A. Effect of menopause duration and biopsychosocial factors on quality of life of women in Kediri District, East Java. J Matern Child Heal 2017;02(02):125–136. DOI: 10.26911/THEJMCH.2017.02.02.04.
Santoro N, Roeca C, Peters BA, et al. The menopause transition: Signs, symptoms, and management options. J Clin Endocrinol Metab 2021;106(1):1–15. DOI: 10.1210/clinem/dgaa764.
Yuksel N, Evaniuk D, Huang L, et al. Guideline No. 422a: Menopause: Vasomotor symptoms, prescription therapeutic agents, complementary and alternative medicine, nutrition, and lifestyle. J Obstet Gynaecol Can 2021;43(10):1188–1204.e1. DOI: 10.1016/j.jogc.2021.08.003.
Palacios S, Stevenson JC, Schaudig K, et al. Hormone therapy for first-line management of menopausal symptoms: Practical recommendations. Womens Health (Lond Engl) 2019;15:1745506519864009. DOI: 10.1177/1745506519864009.
Roa-Díaz ZM, Raguindin PF, Bano A, et al. Menopause and cardiometabolic diseases: What we (don't) know and why it matters. Maturitas 2021;152:48–56. DOI: 10.1016/j.maturitas.2021. 06.013.
Sader MA, Celermajer DS. Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res 2002;53(3):597–604. DOI: 10.1016/s0008-6363(01)00473-4.
Murphy E. Estrogen signaling and cardiovascular disease. Circ Res 2011;109(6):687–696. DOI: 10.1161/CIRCRESAHA.110.236687.
El-Mikkawy DME, EL-Sadek MA, EL-Badawy MA, et al. Circulating level of interleukin-6 in relation to body mass indices and lipid profile in Egyptian adults with overweight and obesity. Egypt Rheumatol Rehabil [Internet]. 2020;47(1):7. DOI: 10.1186/s43166-020-00003-8.
Gierens H, Nauck M, Roth M, et al. Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements. Arterioscler Thromb Vasc Biol 2000;20(7):1777–1783. DOI: 10.1161/01.atv.20.7.1777.
Dosi R, Bhatt N, Shah P, et al. Cardiovascular disease and menopause. J Clin Diagn Res 2014;8(2):62–64. DOI: 10.7860/JCDR/2014/6457.4009.
Zhu D, Chung H-F, Dobson AJ, et al. Age at natural menopause and risk of incident cardiovascular disease: A pooled analysis of individual patient data. Lancet Public Heal 2019;4(11):e553–e564. DOI: 10.1016/S2468-2667(19)30155-0.
Kim OY, Chae JS, Paik JK, et al. Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women. Age (Dordr) 2012;34(2):415–425. DOI: 10.1007/s11357-011-9244-2.
Hashizume M, Yoshida H, Koike N, et al. Overproduced interleukin 6 decreases blood lipid levels via upregulation of very-low-density lipoprotein receptor. Ann Rheum Dis 2010;69(4):741–746. DOI: 10.1136/ard.2008.104844.
Lou Z, Huang Y, Lan Y, et al. Relationship between years since menopause and lipid variation in postmenopausal women: A cross-sectional study. Medicine (Baltimore) 2023;102(2):e32684. DOI: 10.1097/MD.0000000000032684.